TYRO3 and focal segmental glomerulosclerosis: Importantly, similar to what was observed previously with PS/TYRO3 overexpression models, we confirmed that C-10 administration attenuated podocyte injury in vivo in 2 mouse models of glomerular diseases, ADRN as an FSGS model and a diabetic db/db model.